James J. MacDonald - Jun 13, 2022 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP & General Counsel
Signature
/s/ James J. MacDonald
Stock symbol
SANA
Transactions as of
Jun 13, 2022
Transactions value $
$103,926
Form type
4
Date filed
6/15/2022, 06:16 PM
Previous filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Award $5.07K +1.18K +0.28% $4.28 431K May 13, 2022 Direct F1, F2
transaction SANA Common Stock Options Exercise $98.9K +66.8K +15.51% $1.48 497K Jun 13, 2022 Direct
holding SANA Common Stock 7.81K Jun 13, 2022 Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10
holding SANA Common Stock 125K Jun 13, 2022 Held by the KOM Trust
holding SANA Common Stock 125K Jun 13, 2022 Held by the NMM Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Options Exercise $0 -66.8K -56.25% $0.00 52K Jun 13, 2022 Common Stock 66.8K $1.48 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of common stock of Sana Biotechnology, Inc. (the "Issuer") pursuant to the Sana Biotechnology, Inc. 2021 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of November 17, 2021 through May 13, 2022. This transaction is exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 13, 2022.
F3 25% of the shares underlying the option vested and became exercisable on February 14, 2021, and the remainder of the shares underlying the option vest at a rate of 1/36th per month thereafter.